Adjuvant therapy for gastric cancer: Current and future directions

doi:10.3748/wjg.v20.i38.13718

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 20, Issue 38

This Article

Academic Content and Language Evaluation of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (7834)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-2) series, Tables (1-5) series.

Item

Count

PDF

552

WORD

349

HTML

3564

Figures (1-2)

296

Tables (1-5)

271

Sum=5032

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

1328

Download

1474

Sum=2802

Oct 14, 2014 (publication date) through Dec 22, 2024

Times Cited of This Article

Times Cited (31)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Topic Highlight

World J Gastroenterol. Oct 14, 2014; 20(38): 13718-13727
Published online Oct 14, 2014. doi: 10.3748/wjg.v20.i38.13718

Full Size Figure Download Figure

Figure 2 Experimental arms of CRITICS and TOPGEAR trials. ECC: Epirubicin, cisplatin and capecitabine; CRT: Chemo-radiotherapy; FU: Fluorouracil; ECF: Epirubicin, cisplatin, 5-FU; LV: Leucovorin; CT: Chemotherapy.

Citation: Foo M, Leong T. Adjuvant therapy for gastric cancer: Current and future directions. World J Gastroenterol 2014; 20(38): 13718-13727
URL: https://www.wjgnet.com/1007-9327/full/v20/i38/13718.htm
DOI: https://dx.doi.org/10.3748/wjg.v20.i38.13718